THURSDAY, July 28, 2016 — Adlyxin (lixisenatide) has been approved by the U.S.Food and Drug Administration to treat type 2 diabetes in adults, the agency said Thursday in a news release. As the FDA explained, Adlyxin is a “glucagon-like peptide-1 receptor agonist” — a hormonal drug that helps control blood ... Read More »
For many years, the number of type 2 diabetes cases skyrocketed, but researchers say new diagnoses have stabilized in recent years — suggesting more people are living longer with the disease. Researchers in Scotland suggest part of the reason the number of people with the condition continues to increase has ... Read More »
people with diabetes are at higher hazard for developing heart ailment, and people who have a heartassault are at considerably more danger of demise than people who do now not have diabetes, researchers in England report. heart assault sufferers with diabetes are 50 percentage much more likely to die from ... Read More »
While general advice on how to improve diet to reduce diabetes symptoms and obesity can work, researchers in a recent study found a personalized, specific nutrition plan was far more effective for achieving health goals. Researchers at the Joslin Diabetes Center found structured nutrition therapy helped patients reach health goals ... Read More »
Despite the fact that scientists have recognised low testosterone increases risk for diabetes, a currentexamine has shown the impact low stages of the hormone have on blood glucose. Researchers at Tulane college discovered low testosterone increases the chance, which they are sayingshould result in new treatments for men with low ... Read More »
THURSDAY, April 14, 2016 — Adults with diabetes die earlier and suffer longer with disabilities than men and women without the blood-sugar disease, researchers are reporting. Type 1 and type 2 diabetes will shorten the lives of 50-year-old men and women by more than three years. And only about 13 ... Read More »
FRIDAY, April 15, 2016 — Metformin, a commonly prescribed diabetes drug, may reduce the risk of dying from some cancers for postmenopausal women with type 2 diabetes, a new study suggests. The study found that for women with type 2 diabetes and cancer, the odds of dying from cancer appeared ... Read More »
A $1.68 million National Institutes of Health grant will fund research aiming to improve treatment for chronic pancreatitis, as well as further a potential cure for type 1 diabetes, the Medical University of South Carolina announced this week. Earlier studies by researchers at the university showed injecting Alpha 1 anti-trypsin, ... Read More »
WASHINGTON, April 6 — Nearly 10 percent of the global population is living with type 1 or type 2 diabetes, according to a new report showing the number of people with the condition has more than quadrupled in the last 25 years. The World Health Organization released its Global Report ... Read More »
